Steamboat Capital Partners LLC Has $14.79 Million Position in Tenet Healthcare Corporation $THC

Steamboat Capital Partners LLC raised its stake in Tenet Healthcare Corporation (NYSE:THC) by 59.5% during the 2nd quarter, Holdings Channel.com reports. The firm owned 79,074 shares of the company’s stock after buying an additional 29,490 shares during the quarter. Tenet Healthcare accounts for 3.2% of Steamboat Capital Partners LLC’s investment portfolio, making the stock its 8th biggest holding. Steamboat Capital Partners LLC’s holdings in Tenet Healthcare were worth $14,793,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of THC. Empirical Finance LLC purchased a new stake in Tenet Healthcare during the second quarter valued at approximately $586,000. Nykredit A S acquired a new position in shares of Tenet Healthcare during the second quarter worth $600,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Tenet Healthcare during the 2nd quarter valued at $5,504,000. California State Teachers Retirement System grew its stake in Tenet Healthcare by 18,362.2% during the 2nd quarter. California State Teachers Retirement System now owns 18,885,726 shares of the company’s stock worth $3,533,142,000 after buying an additional 18,783,432 shares during the last quarter. Finally, Compass Financial Management LLC purchased a new stake in Tenet Healthcare in the second quarter valued at about $57,000. 95.44% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Mizuho set a $290.00 price target on shares of Tenet Healthcare in a report on Monday, August 10th. Weiss Ratings raised Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, August 20th. Piper Sandler set a $308.00 price target on Tenet Healthcare in a research report on Monday, July 27th. Zacks Research upgraded Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Finally, Raymond James Financial restated an “outperform” rating and issued a $285.00 price objective on shares of Tenet Healthcare in a research note on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $273.00.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 1,152 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $258.80, for a total value of $298,137.60. Following the completion of the sale, the director directly owned 23,653 shares of the company’s stock, valued at $6,121,396.40. This trade represents a 4.64% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Cecil D. Haney sold 1,300 shares of the firm’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $278.03, for a total transaction of $361,439.00. Following the sale, the director owned 12,553 shares of the company’s stock, valued at approximately $3,490,110.59. The trade was a 9.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 109,189 shares of company stock valued at $29,264,109. 0.97% of the stock is owned by company insiders.

Tenet Healthcare Stock Down 2.1%

THC stock opened at $259.37 on Wednesday. The firm’s fifty day moving average is $241.08 and its 200 day moving average is $211.50. The firm has a market cap of $20.88 billion, a PE ratio of 10.00, a P/E/G ratio of 1.01 and a beta of 1.23. Tenet Healthcare Corporation has a one year low of $157.58 and a one year high of $283.05. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business’s revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the business earned $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, research analysts forecast that Tenet Healthcare Corporation will post 21.04 EPS for the current year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.